Table 1.
Clinical characteristics of study subjects
PhenotypenAge (mean)Disease duration (mean)Current IBD medications
PrednisoneAZA/6MPAnti-TNF
  yr yr    
Healthy controls 10 51.4 NA 0% 0% 0% 
Inactive UC 47.8 16.8 33% 50% 0% 
Active UC 51.5 8.8 50% 33% 0% 
Inactive Crohn's 47.5 22.0 0% 17% 33% 
Active Crohn's 36.7 5.0 33% 0% 0% 
PhenotypenAge (mean)Disease duration (mean)Current IBD medications
PrednisoneAZA/6MPAnti-TNF
  yr yr    
Healthy controls 10 51.4 NA 0% 0% 0% 
Inactive UC 47.8 16.8 33% 50% 0% 
Active UC 51.5 8.8 50% 33% 0% 
Inactive Crohn's 47.5 22.0 0% 17% 33% 
Active Crohn's 36.7 5.0 33% 0% 0% 

NA, not applicable.

or Create an Account

Close Modal
Close Modal